DR Horton Says ‘Potential Homebuyers Have Been More Cautious’ as Sales Sink

Dr. The Horton (DHI) on Thursday announced the results of the fiscal second quarter, with less orders and reduced by the expectation of closed houses, as revenue and benefits also reduced by the estimates of analysts.

The company reported an income (EPS) per share of $ 2.58 at a revenue of $ 7.73 billion, below the forecast of the unanimous analysts compiled by the scene alpha.

Dr. Horten had 22,437 net sales orders in the quarter and closed at 19,276 houses, both 15% from year to year. Analysts expected 26,384 net order and 20,205 closing.

Executive Chairman David Ald said, “The 2025 spring has slowed down than the selling season as potential homebuyers have been more alert due to continuous lack of strength and decline in consumer confidence.”

Dr. Horton cut revenue, houses shut down forecasts

The homebuilder cut off his financial 2025 guidance for closed revenue and homes based on the results of the first two quarters and “current market conditions”. Now it has reduced from $ 34.8 billion, $ 36.0 billion to $ 37.5 billion, and 87,000 houses of 87,000 houses decreased from 90,000 to 92,000 in 87,000 homes of 85,000 houses.

Dr. Horton also increased its estimated stock buyback to $ 4 billion for the financial year, which was from $ 2.6 billion to $ 2.8 billion before $ 2.8 billion, as the company’s board approved a new $ 5 billion reproach scheme.

Dr. Horton shares were less than 2% of the shares on Thursday. He entered the day 16% so far this year as homebuilder stock has fallen on concerns that the tariff will increase the cost.